Hostname: page-component-6bf8c574d5-xtvcr Total loading time: 0 Render date: 2025-02-15T09:46:51.004Z Has data issue: false hasContentIssue false
  • English
  • Français

Letter to the Editor

Published online by Cambridge University Press:  02 December 2014

Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letter
Information
Canadian Journal of Neurological Sciences , Volume 27 , Issue 3 , August 2000 , pp. 261
Copyright
Copyright © The Canadian Journal of Neurological 2000

References

3. Mendis, T, Suchowersky, O, Lang, A, Gauthier, S. Management of Parkinson’s disease: a review of current and new therapies. Can J Neurol Sci 1999; 26: 89–103.Google ScholarPubMed
1. Bekkelund, SI, Selseth, B, Mellgren, SI. Parkinson’s disease in a population in Northern Norway. J Norwegian Med Ass 1989; 109: 561–563.Google Scholar
4. Tandberg, E, Larsen, JP, Nessler, EG, et al. The epidemiology of Parkinson’s disease in the county of Rogaland, Norway. Mov Disord 1995; 10: 541–549.CrossRefGoogle ScholarPubMed
2. Vingerhoets, JG, Jallon, P, Galobardes, B, et al. New evidences for a protective effect against epilepsy by neurodegenerative parkinsonism. Neurology 1998; 50: A141.Google Scholar